"Following discussions with researchers at the RBL, the Company will provide additional information and insight into possible joint research plans going forward. It is management’s understanding that few compounds advance to this next stage of SARS-CoV-2 research. "

Read More: https://investorshangout.com/post/view?id=572...z6IMfRHCdI